Octagon Capital Partners logo

Octagon Capital Partners

North America, Ontario, Canada, Toronto

Description

Independent Canadian investment dealer

Investor Profile

Octagon Capital Partners has made 5 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Post Ipo Equity (80%)
  • Series Unknown (20%)

Country Focus

  • Canada (40%)
  • China (40%)
  • United States (20%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Mental Health
  • Product Research
  • Electronics
  • Hardware
  • Management Information Systems
  • Manufacturing
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Octagon Capital Partners frequently co-invest with?

Altium Capital
North America, New York, United States, New York
Co-Investments: 1
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 1
8VC
North America, California, United States, San Francisco
Co-Investments: 1
Avidity Partners
North America, Texas, United States, Dallas
Co-Investments: 2
Sphera Global Healthcare Fund
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 2
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
Deep Track Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 1
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 1
Acorn Bioventures
North America, New York, United States, New York
Co-Investments: 1
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 1

What are some of recent deals done by Octagon Capital Partners?

Cybin

Toronto, Ontario, Canada

Cybin is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.

BiotechnologyHealth CareMental HealthPharmaceutical
Post Ipo EquityMar 13, 2024
Amount Raised: $150,000,000
Sonoma Pharmaceuticals

Petaluma, California, United States

Sonoma Pharmaceuticals develops and markets a global array of treatments for dermatological conditions and advanced tissue care.

Health Care
Post Ipo EquitySep 30, 2020
Amount Raised: $70,000,000
I-Mab Biopharma

Shanghai, Shanghai, China

I-Mab is a dynamic and fast-growing global biotech company exclusively focused on developing innovative biologics.

BiotechnologyPharmaceuticalProduct Research
Post Ipo EquitySep 4, 2020
Amount Raised: $418,000,000
Labrador Iron Mines

Toronto, Ontario, Canada

Labrador Iron Mines is a resource extraction company.

HydroelectricMiningMining TechnologyService Industry
Post Ipo EquityFeb 29, 2012
Amount Raised: $72,452,260
SinoHub

Shenzhen, Guangdong, China

SinoHub was a one-stop-shop for all electronic component supply chain services.

ElectronicsHardwareManagement Information SystemsManufacturingSoftwareSupply Chain Management
Series UnknownFeb 24, 2010
Amount Raised: $4,610,000